Clinical efficacy and pharmacokinetic study of antituberculosis treatment in patients with end-stage renal disease undergoing hemodialysis
{{output}}
Background: Patients with end-stage renal disease (ESRD) undergoing hemodialysis exhibit a 10-25 times greater risk of tuberculosis (TB), underscoring the urgent need for optimized treatment strategies to improve prognosis. ... ...
